Effective Cannabis | Research & Blog
Dravet syndrome is a rare, catastrophic, lifelong form of epilepsy that begins in the first year of life with frequent and/or prolonged seizures. Previously known as Severe Myoclonic Epilepsy of Infancy (SMEI),
In 2013, Survey explored the use of cannabidiol-enriched cannabis in children with treatment-resistant epilepsy. A parent survey was presented to a Facebook group dedicated to sharing information about the use of cannabis to treat their child’s seizures. Background: Survey consisted of 24 questions that measured clinical factors, including diagnosis and seizure types. As a result .. Read More
In 2014, Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy BACKGROUND: This survey explored the use of cannabidiol-enriched cannabis in children with treatment-resistant epilepsy. The survey was presented to parents belonging to a Facebook group dedicated to sharing information about the use of cannabidiol-enriched cannabis to treat their child’s seizures. .. Read More
in 2017, Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome BACKGROUND: In this double-blind, placebo-controlled trial, we randomly assigned 120 children and young adults with the Dravet syndrome and drug-resistant seizures to receive either cannabidiol oral solution at a dose of 20 mg per kilogram of body weight per day or placebo, in .. Read More
In 2013, Parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy BACKGROUND: Thirteen children had Dravet syndrome, four had Doose syndrome, and one each had Lennox-Gastaut syndrome and idiopathic epilepsy. The average number of anti-epileptic drugs (AEDs) tried before using cannabidiol-enriched cannabis was 12. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
In 2015, Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy BACKGROUND: Sought to document the experiences of children with IS and/or LGS who have been treated with CBD-enriched cannabis preparations. We conducted a brief online survey of parents who administered CBD-enriched cannabis preparations for the treatment of their children’s epilepsy. We specifically recruited .. Read More
